Navigation Links
Beaumont Launches 1st U.S. Adult Human Stem Cell Study for Stress Urinary Incontinence
Date:3/10/2009

Stem cells harvested from the patient's leg are used to strengthen weak muscles that can lead to urinary leakage.

Royal Oak, Mich. (PRWEB) March 10, 2009 -- Urologists at Beaumont Hospital (http://www.beaumonthospitals.com) are first in the United States to treat stress urinary incontinence using a person's own stem cells through a research study. The stem cells are used to strengthen weak muscles that control urination.

"If successful, (autologous) muscle-derived stem cell therapy could offer new hope to people with stress urinary incontinence and offer them a life free of urinary leakage," says Urology department Chairman Kenneth Peters, M.D., who is leading the research at Beaumont.

Stress urinary incontinence - the cause of leakage with coughing or physical activity - affects about 13 million Americans, most of them women, but also men who have had a prostatectomy (surgery for prostate cancer).

Current treatments, including medicine, exercises and surgery, are not always effective and may have undesirable side effects.

The stem cells from 48 female research participants age 18 or older will be collected at Beaumont Hospital, Royal Oak, and duplicated. The cells will then be injected into the muscles that control urination to strengthen them and prevent leakage.

Participation will last 12-14 months, and will include physical exams, procedures to assess the bladder, completing voiding diaries and questionnaires and a variety of diagnostic tests. A small sample of the participant's thigh muscle will be collected, which is the source of the stem cells. Pregnant or nursing women may not participate.

There is no charge for study-related tests and procedures. Participants will be reimbursed up to $385 for travel to and from the hospital.

Call Debbie Hasenau, R.N., Urology research, at 248-551-3355 for more information.

Beaumont urologists offer endoscopic, robotic and minimally invasive laparoscopic surgical options as well as traditional surgeries, in addition to treatment, for kidney stones; painful bladder conditions including over-active bladder; incontinence; sexual dysfunction; urologic cancer; prostate conditions; male infertility; voiding dysfunction; and erectile dysfunction. Doctors at Beaumont are pioneering a revolutionary nerve rerouting surgery to help adults with spinal cord injuries or children with spina bifida gain bladder control and are first in the United States to research using a person's own stem cells to treat stress urinary incontinence. Beaumont's Urology program is ranked 31st out of 50 on U.S. News & World Report's "America's Best Hospitals" list. Visit Beaumont on the Web at http://www.beaumonthospitals.com.

###

Read the full story at http://www.prweb.com/releases/urinary/incontinence/prweb2203954.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project
2. Beaumont Sees Results in Nations 1st Urinary Nerve Rewiring Surgeries for Spina Bifida Patients
3. OU, Beaumont Name Dean of New Medical School
4. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
5. UPMC Health Plan Launches New Personal Health Record
6. HealthInsuranceFinders.com Launches Video Contest for Young Directors
7. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
8. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
9. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
10. Mannatech Launches Phase One of New Sales and Training Tools
11. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Beaumont Launches 1st U.S. Adult Human Stem Cell Study for Stress Urinary Incontinence
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: